Danaher Beats the Street

Today was Danaher’s (DHR) turn. The company reported a blow-out earnings report for its fiscal Q1. Danaher made $2.52 per share which was far above Wall Street’s consensus of $1.75 per share.

The company now sees Q2 revenue growth “in the mid-20 percent range,” and full-year revenue growth “in the high-teens percent range.”

Rainer M. Blair, President and Chief Executive Officer, stated, “We had a very strong start to the year, delivering better-than-expected first quarter results across our portfolio. This broad-based outperformance was driven by double-digit core revenue growth in our base business, and our ongoing contributions to the development and production of COVID-19 vaccines, therapeutics and diagnostic tests. Our record top-line performance contributed to strong earnings per share growth and cash flow generation and, we believe, continued market share gains in many of our businesses.”

The stock has been up as much as 4.8% today.

This morning’s jobless claims report was 547,000, which is another pandemic low. That was 50,000 below forecasts. It’s possible that the next nonfarm payrolls report could top one million.

Posted by on April 22nd, 2021 at 11:28 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.